G9A upregulation in breast and cervical cancers was further confirmed using the Genevestigator database [26], which showed an increase in G9A expression in patient cancer tissues and the corresponding cancer cell lines compared to normal breast and cervical tissues respectively (S1 Fig). Here, EHMT2 is linked to cancer.